Quantum Cyber N.V. Gross Profit
Quantum Cyber N.V. (QUCY) reported Gross Profit of $189.59 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Income Statement › Gross Profit
ifrs-full:GrossProfit · last filed 2025-09-26
- Quantum Cyber N.V. gross profit for the quarter ending 2023-12-31 was $134.73K, a 271.21% increase year-over-year.
- Quantum Cyber N.V. gross profit for the quarter ending 2023-09-30 was $87.19K, a 368.41% increase year-over-year.
- Quantum Cyber N.V. gross profit for the quarter ending 2023-06-30 was $148.80K, a 84.13% increase year-over-year.
- Quantum Cyber N.V. gross profit for the quarter ending 2022-12-31 was $36.30K.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $189.59K 6-K · filed 2025-09-26 | ||||
| 2024-12-31 | $574.88K 20-F · filed 2025-03-31 | ||||
| 2024-06-30 | $319.04K 6-K · filed 2025-09-26 | ||||
| 2023-12-31 | $134.73K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $221.92K derived: sum of 2 quarters · filed 2025-03-31 | $370.72K derived: sum of 3 quarters · filed 2025-03-31 | $509.66K 20-F · filed 2025-03-31 | |
| 2023-09-30 | $87.19K 6-K · filed 2023-11-16 | $235.98K derived: sum of 2 quarters · filed 2023-11-16 | $374.93K 6-K · filed 2023-11-16 | ||
| 2023-06-30 | $148.80K 6-K · filed 2023-08-15 | $287.74K 6-K · filed 2024-10-18 | |||
| 2022-12-31 | $36.30K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $54.91K derived: sum of 2 quarters · filed 2025-03-31 | $135.72K derived: sum of 3 quarters · filed 2025-03-31 | $182.15K 20-F · filed 2025-03-31 | |
| 2022-09-30 | $18.61K 6-K · filed 2023-11-16 | $99.43K derived: sum of 2 quarters · filed 2023-11-16 | $145.85K 6-K · filed 2023-11-16 | ||
| 2022-06-30 | $80.81K 6-K · filed 2023-08-15 | $127.24K 6-K · filed 2023-08-15 | $120.80K 6-K · filed 2022-09-07 | ||
| 2021-12-31 | $177.62K 20-F · filed 2024-04-09 | ||||
| 2021-06-30 | $352.54K 6-K · filed 2022-09-07 | ||||
| 2020-12-31 | $123.08K 20-F · filed 2023-04-07 | ||||
| 2019-12-31 | -$61.27K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |